Dark

OMCL
Omnicell Inc
stock NASDAQ

At Close

May 23, 2025 3:59:48 PM EDT

28.24USD-2.080%(-0.60)760,523

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 22, 2025 9:07:30 AM EDT

30.06USD+4.230%(+1.22)0

After-hours

May 23, 2025 4:34:30 PM EDT

28.23USD-0.035%(-0.01)2,810

OverviewOptionsHistoricalExchangesShortsNews

Jan 5, 2022

04:01PM EST Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022 Business Wire

Jan 4, 2022

08:08AM EST Omnicell Buys MarkeTouch Media For $82 Mln RTTNews

08:05AM EST Omnicell Acquires MarkeTouch Media For Cash Consideration Of $82M Benzinga

08:01AM EST Omnicell Acquires MarkeTouch Media Business Wire

Dec 29, 2021

04:06PM EST Omnicell Completes Acquisition Of ReCept RTTNews

Dec 6, 2021

10:05AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021 Benzinga

07:30AM EST Wells Fargo Initiates Coverage On Omnicell with Overweight Rating, Announces Price Target of $203 Benzinga

Dec 2, 2021

09:02AM EST Omnicell, Inc. (OMCL), a provider of healthcare tools and solutions, said on Thursday that it has signed a definitive agreement with ReCept Holdings, Inc., a provider of specialty pharmacy management services, to acquire its business for a total cash consideration of $100 million. RTTNews

08:35AM EST Omnicell To Acquire ReCept For About $100 Mln RTTNews

08:32AM EST Omnicell To Acquire ReCept For Total Aggregate Cash Consideration Of $100M Benzinga

08:30AM EST Omnicell to Acquire ReCept Business Wire

Dec 1, 2021

08:34AM EST BTIG Maintains Buy on Omnicell, Raises Price Target to $220 Benzinga

Nov 22, 2021

04:05PM EST Omnicell to Present at Upcoming Investor Conferences Business Wire

Nov 10, 2021

08:36AM EST Omnicell And Fresenius Kabi Collaborate To Enhance Management Of Controlled Substances In U.S. Hospitals Benzinga

Nov 3, 2021

10:03AM EDT Craig-Hallum Maintains Buy on Omnicell, Raises Price Target to $205 Benzinga

Nov 2, 2021

10:57AM EDT Recap: Omnicell Q3 Earnings Benzinga

10:52AM EDT Omnicell Q3 Adj. EPS $1.08 Beats $0.91 Estimate, Sales $296.00M Beat $284.74M Estimate Benzinga

10:52AM EDT Omnicell Sees Q4 Adj. EPS $0.90-$0.95 vs $1.01 Est., Sales $308M-$313M vs $303.81M Est.; Sees FY21 Adj. EPS $3.80-$3.85 vs $3.73 Est., Sales $1.13B-$1.17B vs $1.11B Est. Benzinga

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

07:41AM EDT Omnicell Q3 EPS $0.61 Vs $0.20 Last Year RTTNews

07:35AM EDT Tucson VA Medical Center Selects Omnicell's Central Pharmacy Dispensing Service to Enhance Medication Inventory Management Business Wire

07:30AM EDT Omnicell Announces Financial Results for Third Quarter 2021 Business Wire

Oct 26, 2021

09:49AM EDT BTIG Maintains Buy on Omnicell, Raises Price Target to $200 Benzinga

Oct 11, 2021

04:01PM EDT Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021 Business Wire

Oct 6, 2021

10:12AM EDT FDS Amplicare Hosts Webinar to Advise Pharmacists on Assisting Customers During PR Newswire

Sep 9, 2021

04:25PM EDT Omnicell Completes Acquisition Of FDS Amplicare RTTNews

Aug 18, 2021

04:31PM EDT Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 Release Benzinga

Jul 29, 2021

11:11AM EDT Omnicell Beats On Q2 Earnings, Issues Promising Q3 Guidance Benzinga

08:29AM EDT Omnicell Sees Q3 Adj. EPS $0.89-$0.94 vs $0.92 Est., Sales $281M-$286M vs $278.67M Est.; Sees FY21 Adj. EPS $3.65-$3.75 vs $3.59 Est., Sales $1.1B-$1.115B vs $1.1B Est. Benzinga

08:25AM EDT Omnicell Q2 Adj. EPS $0.97 Beats $0.82 Estimate, Sales $272.74M Beat $268.51M Estimate Benzinga

08:18AM EDT Spartanburg Partners With Omnicell To Drive Improved Clinical And Operational Outcomes RTTNews

08:15AM EDT Spartanburg Regional Healthcare System Partners with Omnicell to Drive Improved Clinical and Operational Outcomes Business Wire

08:11AM EDT Omnicell Q2 Total Revenues $272.7 Mln Up $73.1 Mln Or 36.6% From Last Year RTTNews

08:00AM EDT Omnicell Announces Financial Results for Second Quarter 2021 Business Wire

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 26, 2021

08:34AM EDT Omnicell, Inc. (OMCL), a provider of medication management solutions and adherence tools for health systems and pharmacies, announced Monday it has entered into a definitive agreement with pharmacy software solutions provider FDS Amplicare to acquire its business for total aggregate cash consideration of $177 million, subject to customary adjustments. RTTNews

08:06AM EDT Omnicell To Acquire FDS Amplicare For Total Aggregate Cash Consideration Of $177 Mln RTTNews

08:02AM EDT Omnicell To Acquire FDS Amplicare For $177M Benzinga

08:00AM EDT Omnicell to Acquire FDS Amplicare Business Wire

Jul 12, 2021

08:31AM EDT Omnicell Appoints Edward Bousa to Board of Directors Business Wire

Jul 7, 2021

08:00AM EDT Chartwell Enhances IV Preparations with Omnicell(r) IVX Workflow Business Wire

Jun 23, 2021

11:48AM EDT Where Omnicell Stands With Analysts Benzinga

08:04AM EDT Piper Sandler Maintains Overweight on Omnicell, Raises Price Target to $188 Benzinga

Jun 9, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021 Benzinga

07:50AM EDT JP Morgan Initiates Coverage On Omnicell with Neutral Rating, Announces Price Target of $146 Benzinga

May 24, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021 Benzinga

06:43AM EDT BTIG Initiates Coverage On Omnicell with Buy Rating, Announces Price Target of $165 Benzinga

Apr 30, 2021

10:02AM EDT Piper Sandler Maintains Overweight on Omnicell, Raises Price Target to $152 Benzinga

09:38AM EDT Benchmark Maintains Buy on Omnicell, Raises Price Target to $160 Benzinga

Apr 29, 2021

05:14PM EDT Omnicell: Q1 Earnings Insights Benzinga

04:46PM EDT Scripps Health Selects Omnicell Medication Management Solutions to Help Improve Clinical and Operational Efficiency Business Wire

04:24PM EDT Omnicell Sees FY21 EPS $3.50-$3.70 Vs. $3.53 Est., Sales $1.09B-$1.15B Vs. $1.09B Est Benzinga

04:23PM EDT Omnicell Sees Q2 EPS $0.80-$0.85 Vs. $0.84 Est., Sales $265M-$270M Vs. $263.54M Est Benzinga

04:22PM EDT Omnicell Q1 EPS $0.83 Beats $0.66 Estimate, Sales $251.80M Beat $246.70M Estimate Benzinga

04:01PM EDT Omnicell Announces Financial Results for First Quarter 2021 Business Wire

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 27, 2021

08:23AM EDT Omnicell's EnlivenHealth Partners With Twilio to Accelerate Launch of Transformative Patient Communications Solutions Benzinga

08:01AM EDT EnlivenHealth Partners With Twilio to Accelerate Launch of Transformative Patient Communications Solutions Business Wire

Apr 7, 2021

08:01AM EDT Aultman Health Foundation to Enhance Medication Management with Omnicell's Central Pharmacy Dispensing Service Business Wire

Apr 1, 2021

04:05PM EDT Omnicell to Release First Quarter 2021 Financial Results on April 29, 2021 Business Wire

Mar 18, 2021

08:16AM EDT The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq Benzinga

Mar 17, 2021

07:43AM EDT The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes Benzinga

Mar 16, 2021

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

Mar 3, 2021

08:01AM EST The Christ Hospital Health Network Selects Omnicell's Central Pharmacy Dispensing Service to Enhance Medication Inventory Management Business Wire

Feb 22, 2021

08:38AM EST Omnicell Names Christine Mellon EVP, Chief People Officer RTTNews

08:30AM EST Omnicell Appoints Christine Mellon as Chief People Officer Business Wire

Feb 12, 2021

04:01PM EST Omnicell to Present at Upcoming Investor Conferences Business Wire

Feb 2, 2021

10:07AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2021 Benzinga

08:22AM EST 10 Biggest Price Target Changes For Tuesday Benzinga

06:29AM EST Piper Sandler Upgrades Omnicell to Overweight, Raises Price Target to $147 Benzinga

Feb 1, 2021

04:41PM EST Omnicell: Q4 Earnings Insights Benzinga

04:03PM EST Omnicell Sees FY21 Adj. EPS $3.40-$3.60 vs $3.44 Estimate, Sales $1.09B-$1.15B vs $1.09B Est. Benzinga

04:02PM EST Omnicell Sees Q1 Adj. EPS $0.64-$0.69 vs $0.72 Estimate, Sales $243M-$248M vs $250M Estimate Benzinga

04:01PM EST Omnicell Reports Fiscal Year and Fourth Quarter 2020 Results Business Wire

04:01PM EST Omnicell Q4 Adj. EPS $0.91 Beats $0.80 Estimate, Sales $249.20M Beat $245.50M Estimate Benzinga

04:00AM EST Earnings Scheduled For February 1, 2021 Benzinga

Jan 30, 2021

01:19PM EST The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More Benzinga

Jan 29, 2021

10:05AM EST Preview: Omnicell's Earnings Benzinga

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 26, 2021

04:02PM EST WVU Medicine Selects Omnicell One Intelligence Solution to Drive Better Pharmacy Inventory Management, Optimize Costs, and Support Better Patient Care Benzinga

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 13, 2021

02:41PM EST Omnicell shares were trading higher after the company issued FY20 and FY21 sales guidance above analyst estimates. Benzinga

08:21AM EST Omnicell Expects 2020 Total Revenues To Be $890 Mln-$892 Mln, Exceeding Its Prior Guidance Of $881 Mln-$887 Mln RTTNews

08:03AM EST Omnicell Sees FY25 Adj. Operating Margin ~25% Of Adj. EBITDA Margin Benzinga

08:03AM EST UPDATE: Omnicell Raises FY21 Sales Guidance To $1.085B-$1.105B vs $1.03B Estimate Benzinga

08:02AM EST Omnicell Sees FY20 Sales $890M-$892M vs $884.3M Estimate Benzinga

08:02AM EST Omnicell Raises FY21 Guidance Benzinga

08:01AM EST Omnicell Announces Preliminary Fiscal Year 2020 Financial Results Business Wire

Jan 11, 2021

08:28AM EST Omnicell's EnlivenHealth Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges Benzinga

Jan 4, 2021

08:00AM EST Omnicell to Partner with Guy's and St Thomas' NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre as Part of Expansion of Omnicell Systems Across the South East London NHS Integrated Care System Business Wire

Dec 21, 2020

04:30PM EST Owensboro Health to Deploy Omnicell's Technology-Enabled Services to Improve Safety and Efficiency in Medication Management Business Wire

Dec 15, 2020

05:02PM EST Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference Business Wire

Dec 10, 2020

07:42AM EST The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations Benzinga

Dec 8, 2020

11:24AM EST Berenberg Initiates Coverage On Omnicell with Buy Rating, Announces Price Target of $145 Benzinga

Nov 11, 2020

08:01AM EST New National Survey Finds the Majority of Retail Pharmacies and Health Plans Are Concerned About People Actually Taking the COVID-19 Vaccine Once It's Available Business Wire

Nov 10, 2020

08:12AM EST Omnicell Announces Latest Innovations To Portfolio Of Medication Management Solutions RTTNews

08:01AM EST Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services at Omnicell Illuminate 2020 Business Wire

Nov 9, 2020

08:14AM EST Omnicell Announces New Partnership With Allegheny Health Network RTTNews

08:01AM EST Allegheny Health Network Partners with Omnicell to Drive Safety and Efficiency for Medication Management Across Western Pennsylvania Network Business Wire

Nov 6, 2020

05:27PM EST Omnicell to Present at Upcoming Investor Conferences Business Wire

Oct 28, 2020

11:00AM EDT Wells Fargo Maintains Equal-Weight on Omnicell, Raises Price Target to $84 Benzinga

10:05AM EDT Shares of Omnicell Inc. (OMCL) are currently trading at $90.02, up $4.43 or 5.18% in the Wednesday's regular trading session, with trading volume of over 201K versus an average volume of 457K shares. The stock has been trading in the range of $54.24 - $94.85 for the past one year. RTTNews

09:37AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

07:44AM EDT Cantor Fitzgerald Maintains Overweight on Omnicell, Raises Price Target to $95 Benzinga

07:39AM EDT Benchmark Maintains Buy on Omnicell, Raises Price Target to $100 Benzinga

Oct 27, 2020

04:59PM EDT Omnicell: Q3 Earnings Insights Benzinga

04:04PM EDT Omnicell Q3 EPS $0.60 Beats $0.49 Estimate, Sales $213.70 Miss $208.46M Estimate Benzinga

04:01PM EDT Omnicell Reports Third Quarter 2020 Results Business Wire

08:25AM EDT The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings Benzinga

04:18AM EDT Earnings Scheduled For October 27, 2020 Benzinga

Oct 26, 2020

10:18AM EDT Omnicell Earnings Preview Benzinga

Oct 22, 2020

08:03AM EDT Lehigh Valley Health Network Chooses Omnicell Solutions to Enhance Clinical and Operational Outcomes and Streamline Medication Management Business Wire

Oct 20, 2020

08:02AM EDT Memorial Hospital At Gulfport Selects Omnicell Central Pharmacy Dispensing Service To Enhance Medication Safety And Dispensing Efficiency Benzinga

Oct 6, 2020

08:00AM EDT Omnicell Launches EnlivenHealth(tm) to Aid Retail Pharmacies and Health Plans In Improving Patient Adherence, Quality Measures, and Retention Business Wire

Oct 1, 2020

04:04PM EDT Omnicell Completes Acquisition Of Pharmaceutical Strategy Group's Leading 340B Software-Enabled Service Business RTTNews

Sep 29, 2020

04:53PM EDT Omnicell to Release Third Quarter 2020 Earnings Results on October 27, 2020 Business Wire

Sep 23, 2020

06:48AM EDT Omnicell Prices $500 Mln 0.25% Convertible Senior Notes Offering RTTNews

06:45AM EDT Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium) Business Wire

Sep 22, 2020

07:04AM EDT Omnicell Announces Proposed Private Placement Of $500 Mln Of Convertible Senior Notes RTTNews

07:00AM EDT Omnicell Announces Proposed Private Placement of $500 Million of Convertible Senior Notes Business Wire

Sep 1, 2020

04:15PM EDT Omnicell to Present at Upcoming Investor Conferences Business Wire

Aug 17, 2020

08:00AM EDT Peninsula Regional Medical Center Extends Partnership With Omnicell to Enhance Safety and Efficiency in Sterile Compounding Business Wire

Aug 12, 2020

08:07AM EDT Omnicell To Acquire Pharmaceutical Strategy Group's 340B Software-Enabled Service Business For $225 Mln RTTNews

08:04AM EDT Omnicell to Acquire Pharmaceutical Strategy Group's 340B Link Business For $225M Benzinga

08:00AM EDT Omnicell to Acquire Pharmaceutical Strategy Group's Leading 340B Software-Enabled Service Business Business Wire

Jul 29, 2020

08:48AM EDT Cantor Fitzgerald Maintains Overweight on Omnicell, Raises Price Target to $90 Benzinga

Jul 28, 2020

05:33PM EDT Omnicell: Q2 Earnings Insights Benzinga

04:06PM EDT Omnicell Q2 EPS $0.37 Beats $0.24 Estimate, Sales $199.60M Beat $183.96M Estimate Benzinga

04:01PM EDT Omnicell Reports Second Quarter 2020 Results Business Wire

04:05AM EDT Earnings Scheduled For July 28, 2020 Benzinga

Jul 21, 2020

04:01PM EDT Omnicell to Release Second Quarter 2020 Earnings Results on July 28, 2020 Business Wire

Jul 20, 2020

08:16AM EDT Omnicell Launches Omnicell One Pharmacy Intelligence Solution RTTNews

08:00AM EDT Omnicell Streamlines Pharmacy Supply Chain Through Cloud-Based Predictive Intelligence Solution Business Wire

document.getElementById("TkhZfF").onerror = function(){this.style.display='none';}; .dark-mode .LpQy8q{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .LpQy8q{ color: #333333; background-color: white; border: 2px solid #333333; }OMCLOmnicell Incstock NASDAQ

OMCL
Omnicell Inc
stock NASDAQ